Back to search
FDAFDA · Food and drugs·Recall number D-0025-2025

OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.

Published October 30, 2024 · Recall initiated: October 15, 2024

Summary

FDA records drug Class II recall D-0025-2025, published October 30, 2024 and initiated October 15, 2024. Recalling firm: Akron Pharma, Inc.; Status: Ongoing; Reported quantity: 10845 bottles; Lot: Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akron Pharma, Inc.
Distributor
Nationwide in the US
Lot
Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06. recalled?

Yes. FDA published recall D-0025-2025 on October 30, 2024. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter